Filing Flows › Teva Pharmaceutical Industries (TEVA) › Q3 2025
Teva Pharmaceutical Industries (TEVA) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 5, 2025
Teva Pharmaceutical Industries (TEVA) reported revenue of $4.5B for the third quarter 2025 (Q3 2025), +3% from a year earlier and +7% from the quarter before. Operating margin was 19.7%, net earnings $433M (9.7% of revenue).
Teva Pharmaceutical Industries, Q3 2025: revenue $4.5B (+3% year over year), operating margin 19.7%, net earnings $433M, operating cash flow $369M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $4.5B | +7% | +3% |
| Gross profit | $2.3B | +10% | +7% |
| Operating profit | $882M | +94% | — |
| Net earnings | $433M | +54% | — |
| Operating cash flow | $369M | +63% | -47% |
| Free cash flow | $233M | +78% | -57% |
What changed
Revenue was $4.5B in Q3 2025, up 3% year over year and up 7% from the previous quarter. Product was the largest line at 87% of revenue. Product added $0.18B year over year (up 5%), 123% of the total change. Product and Service Other declined 30%.
Gross margin was 51.4%, up 1.8 points from a year earlier. Operating profit was $0.88B, a 19.7% margin (up 20.9 points year over year). Operating expenses fell 35% while revenue rose 3%. Net earnings were $0.43B. The effective tax rate was 33.0%.
Operating cash flow was $0.37B (down 47% year over year), 85% of net earnings. Non-cash charges added back $0.25B of depreciation and amortization and $0.03B of share-based compensation. Working capital and other items used $0.35B. Capital expenditures of $0.14B left free cash flow of $0.23B.
Questions
What was Teva Pharmaceutical Industries' revenue in the third quarter 2025?
Teva Pharmaceutical Industries (TEVA) reported revenue of $4.5B for the third quarter 2025 (Q3 2025), +3% from a year earlier and +7% from the quarter before.
Was Teva Pharmaceutical Industries profitable in the third quarter 2025?
Operating profit was $882M (19.7% of revenue) and net earnings $433M.